1-2 of 2
Rachid C. Baz
Close
Sort by
Journal Articles

Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma

Clinical Trials & Observations
Dae Hyun Lee, Abhishek Kumar, Turab Mohammed, Lauren C. Peres, Melissa Alsina, Christina Bachmeier, Brandon J. Blue, Jason Brayer, Sanjay Chandrasekhar, Ariel Grajales Cruz, Gabe De Avila, Hany Elmariah, Rawan Faramand, Ciara Freeman, Michael Jain, Sushmita Khadka, Farhad Khimani, Hien Liu, Taiga Nishihori, Laura B. Oswald, Omar A. Castaneda Puglianini, Kenneth H. Shain, Eric Smith, Rachid C. Baz, Frederick L. Locke, Guilherme H. Oliveira, Mohammed Alomar, Doris K. Hansen
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4247–4257.
https://doi.org/10.1182/bloodadvances.2023009766
Published: 2023
Journal Articles

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi, Christelle M. Colin-Leitzinger, Alexandria M. Shrewsbury, Hitomi Hosoya, Rebecca M. Gonzalez, Christina Copponex, Krista H. Kottra, Vanna Hovanky, Bita Sahaf, Sunita Patil, Aleksandr Lazaryan, Michael D. Jain, Aliyah Baluch, Olga V. Klinkova, Nelli Bejanyan, Rawan G. Faramand, Hany Elmariah, Farhad Khimani, Marco L. Davila, Asmita Mishra, Brandon J. Blue, Ariel F. Grajales-Cruz, Omar A. Castaneda Puglianini, Hien D. Liu, Taiga Nishihori, Ciara L. Freeman, Jason B. Brayer, Kenneth H. Shain, Rachid C. Baz, Frederick L. Locke, Melissa Alsina, Surbhi Sidana, Doris K. Hansen
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6109–6119.
https://doi.org/10.1182/bloodadvances.2022008320
Published: 2022
Includes: Supplemental data